ID: ALA2261434

Max Phase: Preclinical

Molecular Formula: C18H22N2O5S

Molecular Weight: 378.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)C1=C(C)N=C(SCCC(=O)O)NC1c1ccccc1OC

Standard InChI:  InChI=1S/C18H22N2O5S/c1-4-25-17(23)15-11(2)19-18(26-10-9-14(21)22)20-16(15)12-7-5-6-8-13(12)24-3/h5-8,16H,4,9-10H2,1-3H3,(H,19,20)(H,21,22)

Standard InChI Key:  JYPKSMDSADPSKN-UHFFFAOYSA-N

Associated Targets(Human)

Dihydrofolate reductase 3072 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Bifunctional dihydrofolate reductase-thymidylate synthase 52 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Toxoplasma gondii 4585 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 378.45Molecular Weight (Monoisotopic): 378.1249AlogP: 2.74#Rotatable Bonds: 7
Polar Surface Area: 97.22Molecular Species: ACIDHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.41CX Basic pKa: 5.67CX LogP: 0.88CX LogD: -0.57
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.70Np Likeness Score: -0.76

References

1. Saudi MNS, Gaafar MR, El-Azzouni MZ, Ibrahim MA, Eissa MM.  (2008)  Synthesis and evaluation of some pyrimidine analogs against toxoplasmosis,  17  (9): [10.1007/s00044-008-9097-0]

Source